12
Feb 2026
Lay health workers improve blood pressure control in rural Africa
In rural regions of Africa, high blood pressure often goes untreated because health centers are far away and there is a shortage of health professionals.








We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
With tailor-made research projects, we provide insights into what works, for whom, at what cost, and under what circumstances to achieve objectives, such as improved healthcare quality, health outcomes, efficiency and staff satisfaction, we support our clients in making evidence-based decisions.
The process of bringing your healthcare innovation to the market is lengthy and complicated. Besides the clinical or humanistic value that your product generates, for example by decreasing complication rate, prolonging survival, improving patient flow, the economic value needs to be demonstrated to healthcare payers.
We help you prepare yourself for (future) discussions with stakeholders about your innovations. During a 1,5 h discussion, we advise you on how to collect, analyse and present data.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
12
Feb 2026
In rural regions of Africa, high blood pressure often goes untreated because health centers are far away and there is a shortage of health professionals.
READ MORE
12
Feb 2026
The American Society of Hematology (ASH) released guidelines on frontline management of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs), as well as the management of relapsed or refractory disease in this population.
READ MORE
12
Feb 2026
Cataracts remain the leading cause of blindness worldwide among adults over 50, despite major advances in surgical treatment.
READ MORE
12
Feb 2026
Myopia has become a major global public health concern, with rising prevalence and earlier onset among children worldwide.
READ MORE